[go: up one dir, main page]

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Geneticists eye the potential of arXiv

Population biologists turn to pre-publication server to gain wider readership and rapid review of results.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pickrell, J. K. et al. Preprint at http://arxiv.org/abs/1207.5552 (2012).

  2. Ralph, P. & Coop, G. Preprint at http://arxiv.org/abs/1207.3815 (2012).

  3. Ginsparg, P. Nature 476, 145–147 (2011).

    Article  ADS  CAS  Google Scholar 

  4. Wolfe-Simon, F. et al. Science 332, 1163–1166 (2011).

    Article  ADS  CAS  Google Scholar 

  5. Reaves, M. L. et al. Preprint at http://arxiv.org/abs/1201.6643 (2012).

  6. Reaves, M. L. et al. Science 337, 470–473 (2012).

    Article  ADS  CAS  Google Scholar 

Download references

Authors

Related links

Related links

Related links in Nature Research

Researchers aim to chart intellectual trends in arXiv 2012-Feb-24

ArXiv at 20 2011-Aug-10

1000 Genomes Project reveals human variation 2010-Oct-27

Related external links

David Reich

Graham Coop

Richard Neher

Rights and permissions

Reprints and permissions

About this article

Cite this article

Callaway, E. Geneticists eye the potential of arXiv. Nature 488, 19 (2012). https://doi.org/10.1038/488019a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/488019a

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research